premargin

Element List	Explanation
Introduction	Basma Adeem Medical Company announces to its shareholders the results of the Ordinary General Assembly Meeting (first meeting), which was held at (20:00) on Thursday, 01/01/1447 AH corresponding to 06/26/2025 AD, at the company’s main headquarters located in Riyadh - King Abdulaziz Road - Al-Yasmin District, via modern technology (remotely) - using Tadawulati services; after the legal quorum for the validity of the meeting of the Assembly was completed
City and Location of the General Assembly's Meeting	The company's main headquarters is located in Riyadh - King Abdulaziz Road - Al-Yasmin District, through modern technology (remotely) - using Tadawulati services.
Date of the General Assembly's Meeting	2025-06-26 Corresponding to 1447-01-01
Time of the General Assembly’s Meeting	20:00
Percentage of Attending Shareholders	53.91%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	1- Omar Sulaiman Al Ajaji - Chairman of the Board of Directors 2- Osama Abdulrahman Al Shaalan - Vice Chairman of the Board of Directors 3- Mohammed Abdul Aziz Saad Al Bawardi - Managing Director and Chief Executive Officer 4- Azzam bin Omar bin Abdulrahman Al Mufdi - Board Member 5- Ahmed Saleh Al Washil - Board Member
Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf	1- Musab Khaled Al-Hadlaq - Chairman of the Audit Committee 2- Abdulaziz Mohammed Al-Oshan - Member of the Audit Committee
Voting Results on the Items of the General Assembly's Meeting Agenda's	1. The Board of Directors' report for the fiscal year ending December 31, 2024 was reviewed. 2. The financial statements for the fiscal year ending December 31, 2024 were reviewed and approved. 3. The company's auditors' report for the fiscal year ending December 31, 2024 was approved. 4. Approval to discharge the members of the Board of Directors from liability for the fiscal year ending December 31, 2024. 5. Approval of the appointment of RSM Company from among the candidates to review, audit, and examine the semi-annual and annual financial statements for the fiscal year ending December 31, 2025, for a total fee of one hundred and thirty thousand (130,000) Saudi riyals. 6. Approval to disburse (215,000) as a bonus and attendance allowance for members of the Board of Directors for the fiscal year ending on 12-31-2024 AD. 7. Approval of the Board of Directors' authorization to distribute interim dividends to shareholders on a semi-annual or quarterly basis for the fiscal year 2025. 8. Approval of the bylaws, policies, standards, and procedures for membership in the Board of Directors and its subcommittees. 9. Approval of the Board of Directors’ delegation of the authority of the Ordinary General Assembly to authorize the license mentioned in Paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of approval of the General Assembly or until the end of the term of the authorized Board of Directors, whichever is earlier, in accordance with the conditions mentioned in the executive regulations of the Companies Law for listed joint-stock companies. 10. Approval of the Chairman of the Board of Directors, Dr. Omar Suleiman Al-Ajaji, participating in a business that competes with the Company's business. 11. Approval of the Board of Directors member, Mr. Azzam Omar Al-Mofdi, participating in a business that competes with the Company's business.

Basma Adeem Medical Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting)